Bruce M. Rodgers - Oct 28, 2021 Form 4 Insider Report for LM FUNDING AMERICA, INC. (LMFA)

Role
Chairman, CEO and President, Director, 10%+ Owner
Signature
/s/ Bruce M. Rodgers
Stock symbol
LMFA
Transactions as of
Oct 28, 2021
Transactions value $
$0
Form type
4
Date filed
11/1/2021, 05:07 PM
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LMFA Common Stock 21.9K Oct 28, 2021 Bruce M. Rodgers Revocable Trust
holding LMFA Common Stock 21.9K Oct 28, 2021 Carolinn Gould Revocable Trust
holding LMFA Common Stock 853 Oct 28, 2021 BRR Holding, LLC F1
holding LMFA Common Stock 232 Oct 28, 2021 Bruce M. Rodgers IRA
holding LMFA Common Stock 20 Oct 28, 2021 Carollinn Gould IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMFA Stock Option (right to buy) Award $0 +1.8M $0.00 1.8M Oct 28, 2021 Common Stock 1.8M $5.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bruce M. Rogers and Carollinn Gould, husband and wife, and their family, including trusts or custodial accounts of minor children of each of Mr. Rodgers and Ms. Gould, own 100% of the outstanding membership interests of BRR Holding, LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest in the shares.
F2 Options were granted under the LM Funding America, Inc. 2021 Omnibus Incentive Plan ("Plan"). Options will vest as to one-third of option shares on October 28, 2022 and as to 1/36 of the options shares on a monthly basis thereafter until vested in full, subject to acceleration of vesting upon a Change of Control (as defined in the Plan) or upon the Issuer's common stock achieving a closing price of greater than $12.00 for 10 consecutive trading days. Notwithstanding, the options will not be exercisable unless and until the Plan is approved by the Issuer's stockholders within one year of grant date.